The effect of sorafenib (S) starting dose and dose intensity on survival in patients with advanced hepatocellular carcinoma (HCC)

被引：1

作者：

Alghamdi, Mohammed Abdullah

Lee-Ying, Richard

Swiha, Mina

Chan, Kelvin K.

Cheung, Winson Y.

Ho, Maria

Tam, Vincent C.

机构：

[1] Tom Baker Canc Clin, Calgary, AB, Canada

[2] Univ Toronto, Sunnybrook Odette Canc Ctr, Toronto, ON, Canada

[3] BC Canc Agcy, Dept Med Oncol, Vancouver, BC, Canada

[4] Cross Canc Inst, Edmonton, AB, Canada

来源：

关键词：

D O I：

10.1200/JCO.2017.35.4_suppl.400

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

400

引用

页数：1